SELLAS Life Sciences Group, Inc.
- Stock
- Ticker SLS
- ISIN US81642T2096
- Nasdaq
Performance, volatility and drawdowns of SELLAS Life Sciences Group, Inc. since 12/2017, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $15,719. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −99.9% in 01/2024, measured from the peak in 04/2018. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | – | – | – | 0.0 | – | – | – | 0.0 |
| Gross profit | – | – | – | 0.0 | – | – | – | 0.0 |
| Operating income | -6.9 | -6.1 | -6.9 | -7.1 | -8.3 | -9.3 | -11 | -11 |
| Net income | -6.7 | -5.8 | -6.6 | -6.8 | -7.7 | -8.4 | -9.6 | -10 |
| Earnings per share | -0.08 | -0.07 | -0.07 | -0.06 | -0.05 | -0.05 | -0.05 | -0.05 |
| Balance sheet | ||||||||
| Total assets | 19 | 35 | 32 | 52 | 78 | 114 | 145 | 141 |
| Liabilities | 10.0 | 7.2 | 6.2 | 5.9 | 7.5 | 6.8 | 7.7 | 9.3 |
| Equity | 9.5 | 28 | 26 | 46 | 71 | 107 | 138 | 132 |
| Cash | 14 | 28 | 25 | 44 | 72 | 107 | 138 | 135 |
| Cash flow | ||||||||
| Operating cash flow | -7.2 | -9.1 | -7.3 | -7.1 | -4.9 | -8.8 | -7.6 | -5.9 |
| Free cash flow | -7.2 | -9.1 | -7.3 | -7.1 | -4.9 | -8.8 | -7.6 | -5.9 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +262.5%, weakest 2019 at −93.0%. 2 of 8 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 12 Nov 2026 | −$0.05 |
| 11 Aug 2026 | −$0.05 |
| 12 May 2026 | −$0.05 |
| 19 Mar 2026 | −$0.05 |
| 12 Nov 2025 | −$0.06 |
| 12 Aug 2025 | −$0.07 |
| 13 May 2025 | −$0.07 |
| 20 Mar 2025 | −$0.08 |
| 13 Nov 2024 | −$0.10 |
| 13 Aug 2024 | −$0.13 |
| 14 May 2024 | −$0.21 |
| 28 Mar 2024 | −$0.25 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €2.5bn
- Market cap in trading currency
- $2.78bn
- Enterprise value
- $2.65bn
- P/E
- –
- P/S
- –
- P/B
- 21.13
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -1.0%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- –
- Net income
- −$35.8m
- Earnings per share
- −$0.20
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -40.3%
- Return on assets
- -25.3%
Balance sheet and cash flow
- Cash
- $135m
- Cash per share
- $0.66
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 14.92
- Book value per share
- $0.65
- Operating cash flow
- −$27.3m
- Free cash flow
- −$27.3m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 204m
- Volume
- 15.2m
- Avg. volume 3 months
- 6.96m
- Relative volume
- 1.6
Price and technicals
- Price
- $13.66
- 1 day
- −8.1%
- 52-week high
- $19.15
- 52-week low
- $1.39
- Distance to 52-week high
- −28.7%
- Distance to 52-week low
- +882.7%
- Distance to 50-day line
- +22.4%
- Distance to 200-day line
- +50.9%
- RSI (14)
- 56
- Volatility 1M
- 357.7%
Performance
- 1 week
- +73.8%
- 1 month
- +20.4%
- 3 months
- −4.6%
- 6 months
- +75.6%
- YTD
- +262.3%
- 1 year
- +798.7%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has SLS performed since 12/2017?
$10,000 grew to $350 by 20 Nov 2026, which is −31.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is SLS?
Volatility was 120.9% per year, measured on monthly returns. The largest decline from a peak was −99.9%, with the low in 01/2024.
How does SLS compare with a broad equity ETF?
Over the same period Global equities (VT) returned +9.8% per year at 16.0% volatility, SLS returned −31.4% at 120.9%. The correlation of monthly returns was 0.29; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.